| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 16th June 2020 | Patrick K. Lucy | 770 | Exercise of derivative | $3.38 | $2,602.60 |
| 16th June 2020 | Patrick K. Lucy | 770 | Open or private sale | $10.23 | $7,873.33 |
| 2nd March 2020 | Patrick K. Lucy | 17,151 | Exercise of derivative | $3.38 | $57,970.38 |
| 2nd March 2020 | Patrick K. Lucy | 17,151 | Open or private sale | $11.24 | $192,706.92 |
| 27th November 2019 | Patrick K. Lucy | 3,000 | Open or private sale | $10.03 | $30,104.40 |
| 16th September 2019 | Patrick K. Lucy | 1,800 | Open or private sale | $10.00 | $18,000.00 |
| 16th September 2019 | Patrick K. Lucy | 250 | Open or private sale | $10.01 | $2,502.50 |
| 13th September 2019 | Patrick K. Lucy | 3,950 | Open or private sale | $10.01 | $39,532.39 |
| 6th September 2019 | Patrick K. Lucy | 6,000 | Open or private sale | $8.00 | $48,021.00 |
Pfenex
Pfênex, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
Ticker: PFNX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1478121
Employees: 81
Exchange: NYSE American
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
